Business Context and Reporting Period
This Form 8-K Current Report was filed by Herbalife Ltd. on July 28, 2005. The filing discloses the entry into a material definitive agreement regarding changes to the compensation structure for non-employee directors, effective July 29, 2005.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on governance and compensation adjustments.
Material Changes
The Board of Directors adopted the following changes to non-employee director compensation:
- Annual Retainers: Increased to $25,000 for non-independent, non-employee directors.
- Committee Chair Retainers: Increased to $15,000 for the Audit Committee Chair and $5,000 for Chairs of all other committees.
- Meeting Attendance Fees:
- In-person Board meetings: $5,000 per meeting.
- Telephonic Board meetings: $1,000 per meeting.
- Board Committee meetings: $2,500 per meeting.
- Equity Grants: Increased the annual equity grant equivalent for Independent Directors to $100,000.
Additionally, the Board adopted Recommended Stock Ownership Guidelines requiring directors to own Company common shares equal to five times their annual retainer within two years of appointment.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The only unusual item noted is the specific adjustment to the director compensation package.
Investor Verification Checklist
- Verify the total annual cost impact of the new compensation structure on the company's operating expenses.
- Confirm the number of non-employee directors subject to these new rates to calculate aggregate liability.
- Review the attached Exhibit 10.1 for the full summary of material terms.
- Check subsequent filings to ensure directors are meeting the new stock ownership guidelines.